HR 1475, the SBA Disaster Transparency Act, requires the Small Business Administration (SBA) to publish all disaster assistance reports on its website. This bill amends existing law by adding specific language mandating that the SBA "publish on the website of the Administration" reports related to disaster assistance, including those submitted by state and local officials. The key mechanism is a procedural update to existing reporting requirements, ensuring all required reports are publicly accessible online rather than only being submitted internally. This directly affects the SBA (by changing its reporting process) and the public (by providing greater transparency into how disaster aid is distributed). The bill does not alter disaster assistance eligibility or funding levels.
HR 1492 amends the Social Security Act to extend the negotiation period for standard drug manufacturers under the federal drug pricing program. Specifically, it changes the timeframe from 7 years to 11 years for small-molecule drugs (like traditional pills) to negotiate prices with the government, aligning it with the existing 12-year period for complex biologic drugs (like insulin or monoclonal antibodies). This adjustment directly affects pharmaceutical companies that produce small-molecule drugs, giving them a longer window to negotiate pricing terms. The bill makes this change effective as if it had been part of the 2022 law that established the program.
This bill would require states to create a simplified process for out-of-state healthcare providers to join Medicaid and CHIP programs. Qualified providers (those already enrolled in Medicare or another state's program with low fraud risk) could enroll without excessive screening and would be approved for five years. It directly affects children under 21 enrolled in Medicaid or CHIP by expanding access to providers outside their state, particularly in underserved areas. The change applies to all states' Medicaid programs but takes effect three years after enactment.
HR 1500 requires federal agencies to prioritize native plants over non-native plants in landscaping projects at federal facilities (like military bases, parks, and government buildings), where feasible considering cost and maintenance. It mandates agencies to update design standards within 270 days, include native plant requirements in contracts, and consider benefits like supporting pollinators and reducing water use. Agencies must also report annually on implementation, including case studies and environmental impacts, starting two years after the law takes effect. This affects all federal projects involving landscape improvements across all states and territories.
HR 1463 prohibits the use of federal funds to implement, administer, or enforce a specific FDA rule about medical devices known as "laboratory developed tests" (LDTs), published in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286). The bill directly affects the Food and Drug Administration (FDA), preventing it from using taxpayer money to carry out this regulation. Its key mechanism is a straightforward funding ban on the specified rule and any substantially similar future rule. This is a procedural restriction focused solely on blocking financial support for the FDA's LDT regulatory approach.
The SCRUB Act of 2025 requires federal agencies to offset the annual costs of new regulations by repealing existing rules that meet specific criteria, such as those costing over $100 million annually (adjusted for inflation). It directs the new DOGE agency to identify and repeal outdated or overly burdensome rules, prioritizing those that impose high costs on small businesses or lack clear regulatory purpose. Agencies must achieve a 33% reduction in cumulative regulatory costs by July 2026 while maintaining regulatory effectiveness. This directly affects all federal agencies creating regulations and indirectly impacts businesses, consumers, and industries subject to those regulations.
This bill repeals two federal programs that provided funding for electric vehicle (EV) charging infrastructure. It eliminates the grant program for charging/fueling stations under the Infrastructure Investment and Jobs Act and terminates the National Electric Vehicle Infrastructure Formula Program. The bill specifically removes authorization for new grants, cancels unspent funds, and prohibits future use of federal money for these programs. As a result, the federal government will no longer fund or support the development of EV charging networks through these specific mechanisms.
SRES 53 is a bipartisan Senate resolution commemorating the 80th anniversary of the February 19-26, 1945, Battle of Iwo Jima and the iconic U.S. flag-raising on Mount Suribachi on February 23, 1945. It honors the service members who fought in the battle - including those who received the Medal of Honor - and recognizes the strategic importance of the victory in ending World War II. The resolution encourages public commemoration through ceremonies and events, while affirming U.S.-Japan reconciliation and honoring veterans' sacrifices. As a commemorative resolution, it has no binding effect or direct impact on policy or beneficiaries.
This bill, S 641 (Safe and Affordable Drugs from Canada Act of 2025), would allow U.S. individuals to import certain prescription drugs from Canada under specific conditions. It requires drugs to come from FDA-certified Canadian pharmacies, match U.S.-approved drugs in active ingredients and form, be for personal use (not resale) in 90-day quantities, and include a U.S. physician's prescription. The bill excludes controlled substances, biologics, infused drugs, and other high-risk medications. It directly affects U.S. patients seeking lower-cost prescriptions who meet these criteria. The FDA would establish the certification process for Canadian pharmacies within 180 days of enactment.
S 615, the Chemical Tax Repeal Act, repeals excise taxes on specific chemicals and substances currently levied under the Internal Revenue Code. It removes Subchapters B and C of Chapter 38 (which governed these taxes) from the tax code, directly affecting chemical manufacturers and distributors who paid these taxes. The repeal takes effect January 1, 2025, eliminating these specific tax obligations for affected businesses.
Increasing Access to Dental Insurance Act This bill permits individuals to enroll in a dental benefits plan on a health insurance exchange without also enrolling in a qualified health plan.
HR 1438, the *Protecting America’s Agricultural Land from Foreign Harm Act of 2025*, prohibits foreign governments of Iran, North Korea, China, and Russia (and entities they control) from purchasing or leasing U.S. agricultural land, including both public land managed by federal agencies and private land. It also bans such entities from participating in most U.S. Department of Agriculture (USDA) programs if they own or lease agricultural land, with limited exceptions for food safety and health programs. The bill expands disclosure requirements under the Agricultural Foreign Investment Disclosure Act to include leases and security interests, and mandates public data sets showing foreign ownership details and land values. These changes aim to increase transparency around foreign ownership of U.S. farmland while targeting specific foreign governments deemed national security concerns.
